Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,290 INR | -0.12% | -0.98% | -4.91% |
May. 24 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
May. 16 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.91% | 1.17B | |
+15.91% | 41.97B | |
+23.80% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.42% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 524742 Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, Q4 2024 Earnings Call, May 16, 2024